Interactions between Xenobiotics and DME (XEOTIC)
|
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Fipronil |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01302
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Fipronil up-regulates the expression of DME CYP3A43 |
[1] |
Biotoxin |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Cylindrospermopsin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00905
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Cyanotoxin |
DME Modulation |
Cylindrospermopsin inhibits the expression of DME CYP3A43 |
[2] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Aflatoxin B1 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen-mycotoxin |
DME Modulation |
Aflatoxin B1 up-regulates the expression of DME CYP3A43 |
[3] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Diethylhexyl phthalate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01004
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Diethylhexyl phthalate inhibits the expression of DME CYP3A43 |
[4] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Senecionine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01585
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Product |
DME Modulation |
Senecionine induces the drug-metabolizing activity of DME CYP3A43 |
[5] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 6 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen up-regulates the expression of DME CYP3A43 |
[6] |
Arsenic trioxide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Arsenic trioxide up-regulates the expression of DME CYP3A43 |
[7] |
Beta carotene |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00401
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Beta carotene up-regulates the expression of DME CYP3A43 |
[8] |
Carbamazepine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00011
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Carbamazepine up-regulates the expression of DME CYP3A43 |
[9] |
Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine inhibits the expression of DME CYP3A43 |
[10] |
Obeticholic acid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00165
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Obeticholic acid inhibits the drug-metabolizing activity of DME CYP3A43 |
[11] |
Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Diethyltoluamide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00582
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Diethyltoluamide up-regulates the expression of DME CYP3A43 |
[1] |
|
|
|
|
|
|